0 CHECKOUT

China Development Bank Jun 06

  • ID: 2166495
  • June 2006
  • Region: China
  • Standard & Poors
1 of 3

Abstract
Strengths: Strong public policy role. Financial support available from the government. Better asset quality and profitability compared with other Chinese banks. Weaknesses: Uncertainty over the financial arrangements between the bank and the sovereign. Significant banking industry risk in China. The issuer credit ratings on China Development Bank (CDB) reflect the expectations of close support from the People's Republic of China (A-/Positive/A-1) and expectations of a better-defined policy role for CDB. Based on discussions with the government and regulators, Standard & Poor's Ratings Services believes CDB will remain a key development and public policy institution. The draft legislations for the policy banks, including CDB, when enacted, are likely to clarify the bank's role, activities, prudential guidelines, and relations with the government....

Companies mentioned in this report are:
- China Development Bank Corp.
- China (People's Republic of )
- Export-Import Bank of China (The)

Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- China Development Bank Corp.
- China (People's Republic of )
- Export-Import Bank of China (The)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.